Smith DC - Search Results

1

Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial.

Kent E, Sandler H, Montie J, Lee C, Herman J, Esper P, Fardig J, Smith DC. Kent E, et al. Among authors: smith dc. J Clin Oncol. 2004 Jul 1;22(13):2540-5. doi: 10.1200/JCO.2004.10.070. J Clin Oncol. 2004. PMID: 15226322 Clinical Trial.

2

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer.

Pienta KJ, Redman BG, Bandekar R, Strawderman M, Cease K, Esper PS, Naik H, Smith DC. Pienta KJ, et al. Among authors: smith dc. Urology. 1997 Sep;50(3):401-6; discussion 406-7. doi: 10.1016/S0090-4295(97)00228-8. Urology. 1997. PMID: 9301705 Clinical Trial.

3

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Smith DC, et al. J Clin Oncol. 1998 May;16(5):1835-43. doi: 10.1200/JCO.1998.16.5.1835. J Clin Oncol. 1998. PMID: 9586898 Clinical Trial.

4

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.

Redman BG, Smith DC, Flaherty L, Du W, Hussain M. Redman BG, et al. Among authors: smith dc. J Clin Oncol. 1998 May;16(5):1844-8. doi: 10.1200/JCO.1998.16.5.1844. J Clin Oncol. 1998. PMID: 9586899 Clinical Trial.

5

Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer.

Esper P, Hampton JN, Smith DC, Pienta KJ. Esper P, et al. Among authors: smith dc. Oncol Nurs Forum. 1999 Jan-Feb;26(1):107-12. Oncol Nurs Forum. 1999. PMID: 9921573

6

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Among authors: smith dc. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

7

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. Smith DC, et al. Clin Cancer Res. 1999 Jun;5(6):1339-45. Clin Cancer Res. 1999. PMID: 10389917 Clinical Trial.

8

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.

Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Smith DC, et al. J Clin Oncol. 1999 Jun;17(6):1664-71. doi: 10.1200/JCO.1999.17.6.1664. J Clin Oncol. 1999. PMID: 10561202 Clinical Trial.

9

A new concept in cancer care: the supportive care program.

Esper P, Hampton JN, Finn J, Smith DC, Regiani S, Pienta KJ. Esper P, et al. Among authors: smith dc. Am J Hosp Palliat Care. 1999 Nov-Dec;16(6):713-22. doi: 10.1177/104990919901600608. Am J Hosp Palliat Care. 1999. PMID: 11094908 Free article.

10

Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.

Mucci NR, Rubin MA, Strawderman MS, Montie JE, Smith DC, Pienta KJ. Mucci NR, et al. Among authors: smith dc. J Natl Cancer Inst. 2000 Dec 6;92(23):1941-2. doi: 10.1093/jnci/92.23.1941. J Natl Cancer Inst. 2000. PMID: 11106686 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters